Diabetes drugs ‘reduce MS biomarkers’
Diabetes drugs ‘reduce MS biomarkers’
The diabetes drug Actos benefited multiple sclerosis patients with metabolic syndrome in a small trial, a new study has found. Researchers followed 50 MS patients with obesity who were taking metformin or pioglitazone, or who were not treated with either agent; those receiving the active drugs showed reductions in several biomarker measures including MRI lesion burden compared with the untreated controls, according to a report published on Monday in JAMA Neurology...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 968 Views
-
Last post by NHE
-
- 11 Replies
- 3212 Views
-
Last post by NHE
-
- 0 Replies
- 1917 Views
-
Last post by NHE
-
- 0 Replies
- 1153 Views
-
Last post by NHE
-
- 0 Replies
- 1522 Views
-
Last post by frodo
-
- 0 Replies
- 1079 Views
-
Last post by frodo
-
- 0 Replies
- 990 Views
-
Last post by frodo
-
- 0 Replies
- 2347 Views
-
Last post by NHE
-
- 0 Replies
- 1653 Views
-
Last post by frodo